Microperimetric retinal changes in myopic choroidal neovascularization treated with intravitreal ranibizumab

Retina

Volumn 30, Issue 3, 2010, Pages 413-417

  Varano, Monica ^a   Tedeschi, Massimiliano ^a   Oddone, Francesco ^a   Perillo, Loredana ^a   Coppè, Andrea Maria ^a   Parravano, Mariacristina ^a  

^a IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

Anti VEGF drugs; Choroidal neovascularization; CNV; Microperimetry; Myopic CNV; Pathologic myopia; Ranibizumab; Retinal sensitivity; Vascular endothelial growth factor

Indexed keywords

RANIBIZUMAB;

ADULT; CENTRAL RETINAL THICKNESS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIXATION STABILITY; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; MYOPIA; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; RETINAL SENSITIVITY; REVIEW; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL SYSTEM FUNCTION; VISUAL SYSTEM PARAMETERS;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MALE; MIDDLE AGED; MYOPIA, DEGENERATIVE; PERIMETRY; RETINA; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VITREOUS BODY;

EID: 77949381797     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181bd2d23     Document Type: Review

References (17)

1. Yoshida T, Ohno-Matsui K, Yasuzumi K, et al., Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 2003; 110:1297-1305.
2. Blinder KJ, Blumenkranz MS, Bressler NM, et al., Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial-- VIP report no. 3. Ophthalmology 2003;110:667-673.
3. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR; VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular agerelated macular degeneration. N Engl J Med 2004;351:2805-2816.
4. Rosenfeld PJ, Brown DM, Heier JS, et al.; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431.
5. Brown DM, Kaiser PK, Michels M, et al.; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular agerelated macular degeneration. N Engl J Med 2006;355:1432-1444.
6. Kaiser PK, Blodi BA, Shapiro H, Acharya NR; Marina Study Group. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007;114: 1868-1875.
7. Ferrara N, Hillan KJ, Gerber HP, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 2004;3:391-400.
8. Chan WM, Lai TY, Liu DT, et al., Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study. Br J Ophthalmol 2009;93: 150-154.
9. Ikuno Y, Sayanagi K, Soga K, et al., Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results. Am J Ophthalmol 2009;147:94-100.
10. Gharbiya M, Allievi F, Mazzeo L, Gabrieli CB. Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results. Am J Ophthalmol 2009; 147:84-93.
11. Silva RM, Ruiz-Moreno JM, Nascimento J, et al., Short-term efficacy and safety of intravitreal ranibizumab for myopic choroidal neovascularization. Retina 2008;28:1117-1123.
12. Bennett MD, Yee W. Pegaptanib for myopic choroidal neovascularization in a young patient. Graefes Arch Clin Exp Ophthalmol 2007;245:903-905.
13. Midena E, Radin PP, Pilotto E, et al., Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A microperimetry study. Semin Ophthalmol 2004;19: 55-61.
14. Fujii GY, de Juan E Jr, Sunness J, Humayun MS, Pieramici DJ, Chang TS. Patient selection for macular translocation surgery using the scanning laser ophthalmoscope. Ophthalmology 2002; 109:1737-1744.
15. Larsson J, Zhu M, Sutter F, Gillies MC. Relation between reduction of foveal thickness and visual acuity in diabetic macular oedema treated with intravitreal triamcinolone. Am J Ophthalmol 2005;139:802-806.
16. Baba T, Ohno-Matsui K, Yoshida T, et al., Optical coherence tomography of choroidal neovascularization in high myopia. Acta Ophthalmol Scand 2002;80:82-87.
17. Patel PJ, Chen FK, Ikeji F, et al., Repeatability of stratus optical coherence tomography measures in neovascular agerelated macular degeneration. Invest Ophthalmol Vis Sci 2008; 49:1084-1088.